Dover has entered right into a definitive settlement to accumulate Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and control instruments for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s merchandise will expand Dover’s biopharma single-use production providing, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with services in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in revenue during the full year 2022.
When the deal closes, Malema will become part of the PSG business unit inside Dover’s Pumps & Process Solutions segment.
“We see an incredible long-term development alternative in the bioprocessing business pushed by a powerful and growing pipeline of effective novel biologic medication, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more efficient single-use manufacturing processes supports a strong outlook for our choices of single-use parts to end-customers. เกจวัดแรงดันลมราคา imagine that pairing Malema’s know-how with our current portfolio of single-use pumps for biopharma processing will tremendously improve the accuracy and value proposition of our solutions to our clients.”
“We are methodically constructing out our biopharma platform via proactive capacity additions, new product development, and opportunistic acquisitions of highly-attractive niche part applied sciences,” mentioned Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing technology and further strengthens our sensor portfolio with new proprietary technology. In เกจวัดน้ำยาแอร์refco to attractive biopharma purposes, we expect sturdy progress in the semiconductor area on the capacity growth and re-shoring tailwinds.”
Share